Related Experiment Videos
[The role of metalloprotease in pathogenesis of nervous system diseases]
1Katedry i Zakładu Farmakologii Doświadczalnej i Klinicznej w Warszawie.
Abstract:
Matrix Metalloproteases (MMPs) comprise a big family of proteolytic enzymes secreted into extracellular matrix and involved in remodelling of many tissues. The MMPs' activity is regulated on many levels. It is also determined by specific inhibitors known as tissue inhibitors of metalloproteases (TIMPs). Several studies revealed that MMPs have a role not only in physiological processes but also in pathophysiology of nervous system diseases, such as multiplex sclerosis, Guillan-Barré syndrome and strokes. Concerning demyelination MMPs are responsible for degradation of myelin components and facilitation of immune cells migration into inflammatory sites by degrading vascular basement membrane. We still investigate substances with positive clinical effect on the nervous system diseases due to MMPs inactivation.
Insights
Matrix Metalloproteases (MMPs) degrade myelin and aid immune cell entry in nervous system diseases. Research seeks substances to inactivate MMPs for therapeutic benefit.
Area of Science:
- Biochemistry
- Neuroscience
- Immunology
Context:
- Matrix Metalloproteases (MMPs) are enzymes involved in tissue remodeling.
- MMP activity is regulated by tissue inhibitors of metalloproteases (TIMPs).
- MMPs play roles in nervous system pathophysiology, including demyelination, multiple sclerosis, Guillain-Barré syndrome, and stroke.
Purpose:
- To investigate the role of MMPs in nervous system diseases.
- To explore potential therapeutic strategies targeting MMP inactivation.
Summary:
- MMPs contribute to demyelination by degrading myelin components.
- MMPs facilitate immune cell infiltration into inflammatory sites by degrading the vascular basement membrane.
- Ongoing research focuses on identifying substances that inactivate MMPs for treating neurological disorders.
Impact:
- Understanding MMPs' role in demyelination and immune cell migration is crucial for developing new treatments.
- Identifying MMP-inactivating substances could lead to novel therapeutic interventions for neuroinflammatory and neurodegenerative diseases.
- This research contributes to the broader field of neuroimmunology and therapeutic drug development for central nervous system disorders.
Related Concept Videos
Encephalitis ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
The Blood-brain Barrier
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Alzheimer Disease ll: Pathophysiology